Cost Saving Repinex2020-03-23T16:30:34+00:00

HEALTHCARE PROFESSIONALS
RepNewBanner

Cost Saving

Save 50% of the cost of category C ropinirole prescriptions by prescribing Repinex XL.2*

By prescribing Repinex® XL by brand, the average savings for a CCG could still be approximately £15,759 per year, providing the NHS with a total potential annual prescribing cost saving of approximately £3.43 million.1*

Repinex XL Cost Calculator

To find out how much you could save by prescribing Repinex XL, please follow the instructions on the Repinex XL calculator:

View the cost calculator

Repinex XL is part of the cost-saving prolonged-release product range from Aspire Pharma.

  • Over 50% saving on cost of Category C Drug Tariff price;2*
  • Available from all mainline wholesalers;
  • High level of stockholdings;
  • Price Guaranteed***
  • Bioequivalent to the originator.3
ProductCategory C UK Drug Tariff priceRepinex XL price
Ropinirole prolonged-release tablets 2mg x 28 £12.54£6.20
Ropinirole prolonged-release tablets 4mg x 28 £25.09£12.50
Ropinirole prolonged-release tablets 8mg x 28 £42.11£21.00
*50% saving on the cost of Category C ropinirole prolonged-release tablets in the UK Drug Tariff. **Savings based on market data in reference 1. Savings calculated from 2019 spend for 218 CCGs switching their generic and originator brand 2,4 and 8mg ropinirole prolonged-release tablet prescriptions to Repinex XL. ***No change in price subject to no material change to the products or Category C of the UK Drug Tariff until the 2024 PPRS review.
References 1) ePACT data Nov 2018 – Nov 2019 (UK). 2) February 2020 UK Drug Tariff. 3) Data on file. 1010067149 v 4.0 October 2019.

TRUSTED BRANDS.
DEPENDABLE SUPPLY CHAIN.

For further information please call: 01730 231148,
email: info@aspirepharma.co.uk or visit www.aspirepharma.co.uk
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148

For more information about Repinex XL, please see the abbreviated prescribing information.

Revision reference – Repinex XL_18_23.03.2020

More products available
in this range:
Click to view their
individual websites